Manulife (Manufacturers Life Insurance)
BEAM icon

Manulife (Manufacturers Life Insurance)’s Beam Therapeutics BEAM Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.61M Sell
151,403
-5,627
-4% -$156K ﹤0.01% 1270
2025
Q4 		$4.36M Buy
157,030
+11,642
+8% +$297K ﹤0.01% 1217
2025
Q3 		$3.53M Sell
145,388
-4,639
-3% -$92.3K ﹤0.01% 1315
2025
Q2 		$2.55M Sell
150,027
-20,581
-12% -$358K ﹤0.01% 1408
2025
Q1 		$3.33M Buy
170,608
+27,106
+19% +$710K ﹤0.01% 1316
2024
Q4 		$3.56M Sell
143,502
-2,349
-2% -$60K ﹤0.01% 1331
2024
Q3 		$3.57M Buy
145,851
+8,762
+6% +$226K ﹤0.01% 1353
2024
Q2 		$3.21M Buy
137,089
+32,279
+31% +$793K ﹤0.01% 1332
2024
Q1 		$3.46M Buy
104,810
+70,186
+203% +$2.19M ﹤0.01% 1327
2023
Q4 		$942K Buy
34,624
+1,109
+3% +$27.5K ﹤0.01% 1830
2023
Q3 		$806K Buy
33,515
+6,108
+22% +$164K ﹤0.01% 1858
2023
Q2 		$875K Buy
27,407
+1,997
+8% +$64.8K ﹤0.01% 1730
2023
Q1 		$778K Sell
25,410
-170
-0.7% -$6.71K ﹤0.01% 1753
2022
Q4 		$1M Buy
25,580
+343
+1% +$15.4K ﹤0.01% 1608
2022
Q3 		$1.2M Sell
25,237
-468
-2% -$26.7K ﹤0.01% 1532
2022
Q2 		$995K Buy
25,705
+4,471
+21% +$178K ﹤0.01% 1651
2022
Q1 		$1.22M Sell
21,234
-4,516
-18% -$296K ﹤0.01% 1667
2021
Q4 		$2.05K Buy
25,750
+453
+2% +$38.8K ﹤0.01% 1492
2021
Q3 		$2.2M Sell
25,297
-993
-4% -$99.8K ﹤0.01% 1473
2021
Q2 		$3.38M Buy
26,290
+4,070
+18% +$324K ﹤0.01% 1427
2021
Q1 		$1.78M Sell
22,220
-1,389
-6% -$132K ﹤0.01% 1603
2020
Q4 		$1.93M Buy
23,609
+3,813
+19% +$188K ﹤0.01% 1546
2020
Q3 		$487K Buy
+19,796
New +$491K ﹤0.01% 2019

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s BEAM Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Beam Therapeutics (BEAM) stake by 3.6% in Q1 2026, selling an estimated $156K and leaving 151,403 shares worth $3.61M. The position accounts for ﹤0.01% of the portfolio, ranked #1270.

Manulife (Manufacturers Life Insurance) first reported a position in BEAM in Q3 2020 and has held it in 23 quarters since. The position peaked at $4.36M in Q4 2025. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 151,403 shares of Beam Therapeutics worth $3.61M as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 5,627 Beam Therapeutics shares in Q1 2026, an estimated $156K.
  • Beam Therapeutics made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #1270 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Beam Therapeutics in Q3 2020 and has held it in 23 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Beam Therapeutics position peaked at $4.36M in Q4 2025.
  • 251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.